Works matching IS 00099236 AND DT 2004 AND VI 76 AND IP 6

Results: 22

Confusion regarding anticoagulant coumarins in dietary supplements*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 511, doi. 10.1016/j.clpt.2004.08.023
By:
- Booth, Nancy L.;
- Nikolic, Dejan;
- van Breemen, Richard B.;
- Geller, Stacie E.;
- Banuvar, Suzanne;
- Shulman, Lee P.;
- Farnsworth, Norman R.
Publication type:
Article
Publishing work sponsored by the tobacco industry.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 517, doi. 10.1016/j.clpt.2004.08.015
By:
- Stein, C. Michael
Publication type:
Article
A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 519, doi. 10.1016/j.clpt.2004.08.014
By:
- Fukami, Tatsuki;
- Nakajima, Miki;
- Yoshida, Ryoko;
- Tsuchiya, Yuki;
- Fujiki, Yuto;
- Katoh, Miki;
- McLeod, Howard L.;
- Yokoi, Tsuyoshi
Publication type:
Article
Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 528, doi. 10.1016/j.clpt.2004.08.007
By:
- Charasson, Virginie;
- Bellott, Ricardo;
- Meynard, Delphine;
- Longy, Michel;
- Gorry, Philippe;
- Robert, Jacques
Publication type:
Article
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 536, doi. 10.1016/j.clpt.2004.08.020
By:
- Zineh, Issam;
- Beitelshees, Amber L.;
- Gaedigk, Andrea;
- Walker, Joseph R.;
- Pauly, Daniel F.;
- Eberst, Kathleen;
- Leeder, J. Steven;
- Phillips, Michael S.;
- Gelfand, Craig A.;
- Johnson, Julie A.
Publication type:
Article
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 545, doi. 10.1016/j.clpt.2004.08.022
By:
- Hesselink, Dennis A.;
- van Gelder, Teun;
- van Schaik, Ron H. N.;
- Balk, Aggie H. M. M.;
- van der Heiden, Ilse P.;
- van Dam, Thea;
- van der Werf, Marloes;
- Weimar, Willem;
- Mathot, Ron A. A.
Publication type:
Article
CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 557, doi. 10.1016/j.clpt.2004.08.024
By:
- Vormfelde, Stefan Viktor;
- Engelhardt, Sabine;
- Zirk, Alexandra;
- Meineke, Ingolf;
- Tuchen, Franziska;
- Kirchheiner, Julia;
- Brockmöller, Jürgen
Publication type:
Article
Mechanism-based models for topotecan-induced neutropenia.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 567, doi. 10.1016/j.clpt.2004.08.008
By:
- Léger, Frédéric;
- Loos, Walter J.;
- Bugat, Roland;
- Mathijssen, Ron H. J.;
- Goffinet, Marine;
- Verweij, Jaap;
- Sparreboom, Alex;
- Chatelut, Etienne
Publication type:
Article
The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 579, doi. 10.1016/j.clpt.2004.08.016
By:
- Winter, Helen R.;
- Trapnell, Carol B.;
- Slattery, John T.;
- Jacobson, Mark;
- Greenspan, Debra L.;
- Hooton, Thomas M.;
- Unadkat, Jashvant D.
Publication type:
Article
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 588, doi. 10.1016/j.clpt.2004.08.011
By:
- Heeswijk, Rolf P. G. van;
- Khaliq, Yasmin;
- Gallicano, Keith D.;
- Bourbeau, Marc;
- Seguin, Isabelle;
- Phillips, Elizabeth J.;
- Cameron, D. William
Publication type:
Article
Ciprofloxacin greatly increases concentrations and cypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 598, doi. 10.1016/j.clpt.2004.08.018
By:
- Granfors, Marika T.;
- Backman, Janne T.;
- Neuvonen, Mikko;
- Neuvonen, Pertti J.
Publication type:
Article
Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 607, doi. 10.1016/j.clpt.2004.08.019
By:
- Goosen, Theunis C.;
- Cillié, Doré;
- Bailey, David G.;
- Yu, Chongwoo;
- He, Kan;
- Hollenberg, Paul F.;
- Woster, Patrick M.;
- Cohen, Lucinda;
- Williams, J. Andrew;
- Rheeders, Malie;
- Dijkstra, H. Paul
Publication type:
Article
Bioequivalence revisited: Influence of age and sex on CYP enzymes*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 618, doi. 10.1016/j.clpt.2004.08.021
By:
- Bebia, Zourab;
- Buch, Shama C.;
- Wilson, John W.;
- Frye, Reginald F.;
- Romkes, Marjorie;
- Cecchetti, Alfred;
- Chaves-Gnecco, Diego;
- Branch, Robert A.
Publication type:
Article
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 628, doi. 10.1016/j.clpt.2004.08.010
By:
- Wang, Bing;
- Nichol, Janet L.;
- Sullivan, John T.
Publication type:
Article
Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients*.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 639, doi. 10.1016/j.clpt.2004.08.017
By:
- Tirkkonen, Tuire;
- Laine, Kari
Publication type:
Article
Propofol concentrations during the anhepatic phase of living-related donor liver transplantation.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 648, doi. 10.1016/j.clpt.2004.09.003
By:
- Takizawa, Daisuke;
- Hiraoka, Haruhiko;
- Nakamura, Katsunori;
- Yamamoto, Koujirou;
- Horiuchi, Ryuya
Publication type:
Article
Lewis B. Sheiner, 1940-2004.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 650, doi. 10.1016/j.clpt.2004.08.027
By:
- Blaschke, Terrence F.;
- Giacomini, Kathleen M.
Publication type:
Article
A message from the ASCPT membership committee chairperson.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 652, doi. 10.1016/j.clpt.2004.10.003
By:
- Sullivan, John T.
Publication type:
Article
Editorial Board for Index.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 665, doi. 10.1016/S0009-9236(04)00407-2
Publication type:
Article
Copyright Page for Index.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 666, doi. 10.1016/S0009-9236(04)00408-4
Publication type:
Article
Author Index.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 667, doi. 10.1016/S0009-9236(04)00409-6
Publication type:
Article
Subject Index.
Published in:
Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 673, doi. 10.1016/S0009-9236(04)00410-2
Publication type:
Article

Works matching IS 00099236 AND DT 2004 AND VI 76 AND IP 6

Confusion regarding anticoagulant coumarins in dietary supplements<sup>*</sup>.

Publishing work sponsored by the tobacco industry.

A novel polymorphism of human CYP2A6 gene CYP2A617 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo<sup></sup>.

Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38<sup>*</sup>.

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension<sup>*</sup>.

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide<sup>*</sup>.

Mechanism-based models for topotecan-induced neutropenia.

The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)<sup>*</sup>.

The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum<sup>*</sup>.

Ciprofloxacin greatly increases concentrations and cypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism<sup>*</sup>.

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans<sup>*</sup>.

Bioequivalence revisited: Influence of age and sex on CYP enzymes<sup>*</sup>.

Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand<sup>*</sup>.

Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients<sup>*</sup>.

Propofol concentrations during the anhepatic phase of living-related donor liver transplantation.

Lewis B. Sheiner, 1940-2004.

A message from the ASCPT membership committee chairperson.

Editorial Board for Index.

Copyright Page for Index.

Author Index.

Subject Index.